is crucial for effective management and prognosis evaluation in this patient
population. Early recognition
Melamud, Mark M.,
Bobrik, Daria V.,
Brit, Polina I.,
Efremov, Ilia S.,
Buneva, Valentina N.,
Nevinsky, Georgy A.,
Akhmetova, Elvina A.,
Asadullin, , Azat R.,
Ermakov, Evgeny A. (2024) /moderate AWS without DT (n = 97). Blood
sampling was performed after resolution of the acute condition (on 5
Xu, Dongxiao,
Gareev, Ilgiz,
Beylerli, Ozal,
Pavlov, Valentin,
Le, Huang,
Shi, Huaizhang (2024) )
samples, categorizing them into IA and normal groups. This classification was based on the Gene Expression
Asadullina, D.D.,
Gilyazova, I.R.,
Ivanova, E.A.,
Izmailova, S.M.,
Gilyazova, G.R.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2024) , -503, -144) expression levels before and after ICI therapy in plasma
samples obtained from 42 cc